发明名称 PYRAZOLE COMPOUND AND ANTIDIABETIC CONTAINING THE SAME
摘要 PROBLEM TO BE SOLVED: To provide a pyrazole compound or a pharmacologically acceptable salt thereof having liver glycogen phosphorylase inhibitory activity, thus useful as an antidiabetic or diabetes-preventive agent. SOLUTION: The pyrazole compound is represented by the general formula(I)( wherein, ring Q means an aryl group or aromatic heterocyclic group; R<SP>1</SP>means H, a halogen atom, 1-6C alkyl or the like; R<SP>2</SP>means a halogen atom, 1-6C alkyl or the like; R<SP>3</SP>means a halogen atom, OH, a 1-6C alkyl or the like; and R<SP>4</SP>and R<SP>5</SP>each means H, a 1-6C alkyl, 3-8C cycloalkyl or the like ). COPYRIGHT: (C)2007,JPO&INPIT
申请公布号 JP2007191461(A) 申请公布日期 2007.08.02
申请号 JP20060141015 申请日期 2006.05.22
申请人 JAPAN TOBACCO INC 发明人 TAKAGI MASAKI;NAKAMURA TAKESHI;MATSUDA ISAMU;FUKUDA KENJI;OZAWA KOICHI;UEDA YORIHISA;SAKATA KAORU;NOMURA YUKIHIRO
分类号 C07D231/40;A61K31/216;A61K31/415;A61K31/4155;A61K31/4184;A61K31/4192;A61K31/4196;A61K31/42;A61K31/422;A61K31/4245;A61K31/426;A61K31/427;A61K31/428;A61K31/433;A61K31/4439;A61K31/454;A61K31/4545;A61K31/4709;A61K31/4725;A61K31/496;A61K31/497;A61K31/517;A61K31/5377;A61K31/541;A61K31/549;A61K31/64;A61K38/00;A61K38/04;A61K38/28;A61K45/00;A61P3/04;A61P3/06;A61P3/10;A61P9/12;A61P43/00;C07D401/06;C07D401/12;C07D401/14;C07D403/06;C07D403/12;C07D405/12;C07D409/12;C07D413/12;C07D413/14;C07D417/12;C07D417/14 主分类号 C07D231/40
代理机构 代理人
主权项
地址